Related Experiment Video
Updated: Feb 22, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Medication Regimen Complexity and Patient-Reported Adverse Drug Events in Korean Community Pharmacies: A
1College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Republic of Korea.
Medication regimen complexity is linked to fewer reported adverse drug events (ADEs). Older adults and those with complex regimens may under-report ADEs, highlighting the need for patient-centered strategies to improve detection.
Area of Science:
- Pharmacology
- Patient Safety
- Health Services Research
Background:
- Limited evidence exists on the relationship between medication regimen complexity and patient-reported adverse drug events (ADEs).
- Understanding this association is crucial for improving patient safety and medication management in community pharmacy settings.
Purpose of the Study:
- To examine the association between medication regimen complexity and patient-reported ADEs in adults utilizing community pharmacy services.
- To identify factors influencing medication regimen complexity and predictors of ADE reporting.
Main Methods:
- A cross-sectional survey was conducted among 201 adults with prescription experience at Korean community pharmacies.
- Data collected included Medication Regimen Complexity Index-Korea (MRCI-K) scores, medication adherence, ADE reports, comorbidities, polypharmacy, and demographics.
- Multivariable regression models were used to assess determinants of complexity and predictors of ADE reporting.
Main Results:
- Over half (50.2%) of participants reported at least one ADE in the past month.
- Polypharmacy, comorbidities, and multidose dispensing were associated with higher regimen complexity.
- Higher MRCI-K scores and older age were linked to lower odds of reporting ADEs (OR = 0.95 and 0.98, respectively).
Conclusions:
- Increased medication regimen complexity and older age are associated with reduced reporting of adverse drug events.
- This suggests potential under-recognition of ADEs in these patient groups.
- Patient-centered strategies are essential to enhance ADE identification among individuals with complex medication regimens.
Related Concept Videos
Dosage Regimens: Partial Pharmacokinetic Parameters
Drug Dosing: Geriatric Patients
Dosage Regimens: Designs and Approaches
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Drug Toxicity: Risk factors
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
